Author

Ying Wang

Observed names: Wang, Ying, YING WANG

Institution: Jiangsu Hengrui Medicine (China)

Observed institutions: National Medical Products Administration, Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, Zhujiang Hospital, Jiangsu Hengrui Medicine (China), Southern Medical University

ORCID: 0000-0002-5632-486X

Observed ORCID: 0000-0002-5632-486X

OpenAlex ID: A5115601886

The Contractile Apparatus of Airway Smooth Muscle: Biophysics and Biochemistry

1998 · NEWMAN L. STEPHENS, WEILONG LI, et al. · American Journal of Respiratory and Critical Care Medicine · 39

A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects

2025 · Ying Wang, Yuanzhi Cheng, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 5

Population Pharmacokinetics and Pharmacodynamics Modeling for the Use of Recaticimab in Healthy Volunteers and Patients with Hypercholesterolemia

2025 · Chang Shu, Ying Wang, et al. · Clinical Pharmacokinetics · 3

Safety, pharmacokinetics and pharmacodynamics of HWH486 capsules in healthy adults: A randomized, double-blind, placebo-controlled, phase I dose-escalation study

2023 · Man Chen, Shuangqing Du, et al. · International Immunopharmacology · 1

[Prevalence of chromosome 9 abnormalities among pediatric specimens].

2013 · Ying Wang, Yongzheng Peng, et al. · PubMed · 1

Works count: 10

Citation count: 49

H-index: 3

I10-index: 1